Karyotype, microarray or exome: which genetic test?
- Topic
Each genetic test sees a different size of change. Choosing the test that matches the suspected change saves time, money and false reassurance.
What it is
Genetic tests differ in resolution. A karyotype shows whole chromosomes and large rearrangements (aneuploidies, translocations). FISH targets one known region quickly. Chromosomal microarray detects small deletions and duplications across the genome. Single-gene tests and gene panels look for variants in suspected genes; exome or genome sequencing looks at almost all genes at once. Methylation tests detect imprinting disorders, and repeat-expansion tests detect conditions like fragile X. Every test needs pre-test counselling and careful interpretation of uncertain results.
Key facts
- Suspected trisomy or sex chromosome aneuploidy: karyotype (rapid FISH or QF-PCR for urgent answers).
- Unexplained developmental delay, intellectual disability, autism or multiple anomalies: chromosomal microarray first.
- Suspected single-gene disorder with a clear picture (cystic fibrosis, Duchenne): targeted gene test or panel.
- Complex cases with normal microarray: exome or genome sequencing.
- Fragile X needs a repeat-expansion test; Prader–Willi and Angelman need methylation studies; standard sequencing misses both.
Which test sees what
| Test | Sees | Use it for | Misses |
|---|---|---|---|
| Karyotype | Whole chromosomes, large rearrangements | Down, Turner, Klinefelter, balanced translocations | Microdeletions, single-gene variants |
| FISH | One targeted region | Rapid confirmation of a suspected deletion or aneuploidy | Anything outside the probe |
| Chromosomal microarray | Small deletions and duplications genome-wide | Delay, autism, multiple anomalies | Balanced rearrangements, single-gene variants |
| Gene panel or exome | Sequence variants in genes | Suspected single-gene disorders, complex cases | Repeat expansions, methylation defects |
| Methylation or repeat tests | Imprinting errors, triplet repeats | Prader–Willi, Angelman, fragile X | Other changes |
In clinical practice
- Variants of uncertain significance are common in sequencing; they should not be treated as a diagnosis.
- Pre- and post-test counselling helps families understand results, incidental findings and implications for relatives.
Next step / Initial management
- Choose the test by the suspected change; ask the genetics laboratory when unsure.
- Parental testing helps interpret new variants (de novo or inherited).
- Refer to clinical genetics for test selection in complex cases and for counselling about results.
Common traps
- A normal karyotype rules out a genetic cause: it cannot see microdeletions or single-gene variants.
- Exome sequencing finds everything: it misses repeat expansions and methylation defects.
- A variant of uncertain significance is a diagnosis: it is uncertain and needs interpretation and often parental testing.
- Genetic testing needs no counselling: results affect the whole family and need explanation before and after.
Test yourself
Think of the answer, then tap the question to see it.
A child with autism and mild dysmorphism needs a first genetic test. Which one?
Chromosomal microarray (plus fragile X testing).
A newborn with features of Down syndrome needs confirmation. Which test?
Karyotype (with rapid FISH or QF-PCR if an urgent answer is needed); it also shows whether a translocation is present.
Why does exome sequencing miss fragile X syndrome?
Fragile X is a triplet repeat expansion that standard sequencing does not measure; it needs a dedicated repeat test.
Connections
Educational content; it does not replace assessment by a doctor and is not a clinical instruction. If a child has difficulty breathing, cannot drink, vomits everything, has a seizure, is very drowsy, or is a baby under three months with fever, go to an emergency department at once.
Sources: What are the different types of genetic tests?: MedlinePlus Genetics (MedlinePlus, U.S. National Library of Medicine, 2024); Genetic Consultation: MedlinePlus Genetics (MedlinePlus, U.S. National Library of Medicine, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
